VCYT

NASDAQ · Biotechnology

Veracyte Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$39.80

-0.78 (-1.91%)

As of Sep 20, 10:03 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 84%

Hold 2 11%

Sell 1 5%

Price Target

Analyst Price Target +17.7% upside

Low Target $30.44

Average Target $46.85

High Target $57.64

Current Price $39.80

Current
$39.80

Target
$46.85

$30.44 $46.85 avg $57.64

Scenario Analysis

Bear Case

$30.44

-23.5%

Low target

Base Case

$46.85

+17.7%

Avg target

Bull Case

$57.64

+44.8%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$60.91

-34.7% from high

52-Week Low

$29.46

+35.1% from low

50-Day SMA

$40.85

-2.6% vs SMA

200-Day SMA

$34.09

+16.7% vs SMA

RSI (14)

37.6

Neutral

Target vs 52W High

$46.85

-23.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.2%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%